My non-medical interpretation: leronlimab kicks Maraviroc’s ass due to the extraordinary way it inhibits CCR5 that supports innate immune response verses Maraviroc that deep buries into the CCR5 receptor and hinders immune response. Accurate or not?
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.